Literature DB >> 185452

[Plasma-cAMP in primary and secondary hyperparathyroidism (author's transl)].

P Endres, J Happ, H Köhler, P Fiegel.   

Abstract

3 patients with operatively proven primary hyperparathyroidism showed normal plasma cAMP concentrations. 5 patients in chronic dialysis treatment independent of the level of parathyroid hormone had increased plasma cAMP concentrations. These observations suggest that there is under these circumstances no regulation of plasma cAMP by the parathyroid hormone.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 185452     DOI: 10.1007/bf01468953

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  6 in total

1.  [Clinical significance of cyclic adenosine 3', 5'-monophosphate determination in chronic kidney failure].

Authors:  W Schneider; G A Jutzler
Journal:  Med Welt       Date:  1974-07-26

2.  Evaluation of urinary cyclic 3'5'-adenosine monophosphate excretion in the differential diagnosis of hypercalcemia.

Authors:  P H Dohan; K Yamashita; P R Larsen; B Davis; L Deftos; J B Field
Journal:  J Clin Endocrinol Metab       Date:  1972-12       Impact factor: 5.958

3.  A simple direct assay for cyclic AMP in plasma and other biological samples using an improved competitive protein binding technique.

Authors:  K C Tovey; K G Oldham; J A Whelan
Journal:  Clin Chim Acta       Date:  1974-11-08       Impact factor: 3.786

4.  Urinary cyclic adenosine monophosphate as an aid in the diagnosis of hyperparathyroidism.

Authors:  F A Neelon; B M Birch; M Drezner; H E Lebovitz
Journal:  Lancet       Date:  1973-03-24       Impact factor: 79.321

5.  Serum parathyroid hormone levels and renal handling of phosphorus in patients with chronic renal disease.

Authors:  M M Popovtzer; W F Pinggera; M P Hutt; J Robinette; C G Halgrimson; T E Starzl
Journal:  J Clin Endocrinol Metab       Date:  1972-08       Impact factor: 5.958

6.  Effects of parathyroid hormone on plasma and urinary adenosine 3',5'-monophosphate in man.

Authors:  N I Kaminsky; A E Broadus; J G Hardman; D J Jones; J H Ball; E W Sutherland; G W Liddle
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.